4//SEC Filing
JAMISON THOMAS EDWARD 4
Accession 0001140361-11-021774
CIK 0000890846other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 3:30 PM ET
Size
8.8 KB
Accession
0001140361-11-021774
Insider Transaction Report
Form 4
JAMISON THOMAS EDWARD
Director
Transactions
- Sale
common stock
2011-04-11$7.07/sh−10,000$70,690→ 41,725 total
Holdings
- 15,000
Non-qualified stock options
Exercise: $2.38From: 2008-09-18Exp: 2011-09-17→ Common Stock (15,000 underlying) - 15,000
Non-qualified stock options
Exercise: $0.77From: 2009-09-15Exp: 2014-09-14→ Common Stock (15,000 underlying) - 6,175
Non-qualified stock options
Exercise: $4.16From: 2011-09-14Exp: 2017-09-13→ Common Stock (6,175 underlying)
Footnotes (2)
- [F1]Fully vested.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.95 to $7.10 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
Documents
Issuer
UROPLASTY INC
CIK 0000890846
Entity typeother
Related Parties
1- filerCIK 0001205893
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 3:30 PM ET
- Size
- 8.8 KB